<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="announcement"><?origin publisher?><?FILEmeta_FEBS33389 xml ?><?FILEmain xml ?><?FILEgr1 jpg ?><?FILEgr2 jpg ?><?FILEgr3 jpg ?><?FILEgr4 jpg ?><?FILEgr5 jpg ?><front><journal-meta><journal-id journal-id-type="nlm-ta">FEBS Lett</journal-id><journal-title>Febs Letters</journal-title><issn pub-type="ppub">0014-5793</issn><issn pub-type="epub">1873-3468</issn><publisher><publisher-name>Elsevier Science B.V</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">FEBS33389</article-id><article-id pub-id-type="doi">10.1016/j.febslet.2009.07.026</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Transglutaminase 2 and nucleoside diphosphate kinase activity are correlated in epithelial membranes and are abnormal in cystic fibrosis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Treharne</surname><given-names>Kate J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Giles Best</surname><given-names>O.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Mehta</surname><given-names>Anil</given-names></name><email>a.mehta@dundee.ac.uk</email><xref rid="cor1" ref-type="corresp">&#x0204e;</xref></contrib></contrib-group><aff><addr-line>Centre for Cardiovascular and Lung Biology, Division of Medical Sciences, Ninewells Hospital and Medical School, University of Dundee DD1 9SY, United Kingdom</addr-line></aff><author-notes><corresp id="cor1"><label>&#x0204e;</label>Corresponding author. Fax: +44 1382 632597. <email>a.mehta@dundee.ac.uk</email></corresp></author-notes><pub-date pub-type="ppub"><day>03</day><month>9</month><year>2009</year></pub-date><volume>583</volume><issue>17</issue><fpage>2789</fpage><lpage>2792</lpage><history><date date-type="received"><day>6</day><month>4</month><year>2009</year></date><date date-type="rev-recd"><day>16</day><month>6</month><year>2009</year></date><date date-type="accepted"><day>14</day><month>7</month><year>2009</year></date></history><permissions><copyright-statement>&#x000a9; 2009 Elsevier B.V..</copyright-statement><copyright-year>2009</copyright-year><copyright-holder>Federation of European Biochemical Societies</copyright-holder><license><p>This document may be redistributed and reused, subject to <ext-link ext-link-type="uri" xlink:href="http://www.elsevier.com/wps/find/authorsview.authors/supplementalterms1.0">certain conditions</ext-link>.</p></license></permissions><abstract><title>Abstract</title><sec><p>Tissue transglutaminase (tgase2) is a multifunctional enzyme that crosslinks proteins but also acts as a G-protein, differential functions regulated by calcium and GTP. In the epithelial cell membrane, we show that manipulation of tgase2 function by monodansylcadaverine or retinoic acid (RA) alters the activity of a membrane-bound protein kinase, nucleoside diphosphate kinase (NDPK, nm23-H1/H2) that is known to control G-protein function. We find that NDPK function is abnormally low in cystic fibrosis but can be restored by RA treatment in vitro. Our data suggest that tgase2 is overexpressed in cystic fibrosis and affects NDPK function.</p></sec><sec><title>Structured summary</title><p>MINT-<ext-link xlink:href="mint:7219905" ext-link-type="uri">7219905</ext-link>, MINT-<ext-link xlink:href="mint:7219896" ext-link-type="uri">7219896</ext-link>: <italic>tgase2</italic> (uniprotkb:<ext-link xlink:href="uniprotkb:P21980" ext-link-type="uri">P21980</ext-link>) <italic>physically interacts</italic> (MI:<ext-link xlink:href="mi:0914" ext-link-type="uri">0914</ext-link>) with <italic>NDPK</italic> (uniprotkb:<ext-link xlink:href="uniprotkb:P15531" ext-link-type="uri">P15531</ext-link>) by <italic>anti bait coimmunoprecipitation</italic> (MI:<ext-link xlink:href="mi:0006" ext-link-type="uri">0006</ext-link>)</p></sec></abstract><kwd-group><title>Keywords</title><kwd>Fibrosing colonopathy</kwd><kwd>phosphohistidine</kwd><kwd>Cross-linking</kwd><kwd>Cystic fibrosis transmembrane regulator</kwd></kwd-group><kwd-group><title>Abbreviations</title><kwd>NDPK, nucleoside diphosphate kinase</kwd><kwd>CF, cystic fibrosis</kwd><kwd>tgase2, transglutaminase 2, tissue transglutaminase</kwd><kwd>SDS-PAGE, sodium dodecyl sulfate polyacrylamide gel electrophoresis</kwd><kwd>CFTR, cystic fibrosis transmembrane conductance regulator</kwd><kwd>HMW, high molecular weight</kwd><kwd>HBE, 16HBE14o-</kwd><kwd>CFBE, CFBE16o-</kwd><kwd>MDC, monodansylcadaverine</kwd><kwd>RA, retinoic acid</kwd><kwd>WT, wild-type</kwd><kwd>kDa, kiloDaltons</kwd><kwd>AMPK, AMP-activated protein kinase</kwd><kwd>cAMP, cyclic adenosine monophosphate</kwd></kwd-group></article-meta></front><body><sec><label>1</label><title>Introduction</title><p>Cystic fibrosis (CF) results from mutation of the cystic fibrosis transmembrane regulator (CFTR) and leads to widespread organ-damaging fibrosis <xref rid="bib1" ref-type="bibr">[1]</xref> in pancreas, lung and liver <xref rid="bib2" ref-type="bibr">[2]</xref>. This suggests that there may be a profibrotic factor endogenous to CF-affected tissues. Tissue transglutaminase (tgase2) is one candidate, that catalyses the formation of &#x003b5;-&#x003b3;-glutamyl-lysine crosslinks between glutamine (Q) and lysine (K) residues on proteins in a Ca<sup>2+</sup>-dependent manner <xref rid="bib3" ref-type="bibr">[3]</xref>. Normally, this activity is silent inside cells, due to high GTP levels, but crosslinking has nevertheless been implicated in the regulation of tgase2 unrelated enzymatic activity <xref rid="bib4" ref-type="bibr">[4]</xref> and in the regulation of a protein kinase by oligomerisation <xref rid="bib5" ref-type="bibr">[5]</xref>. Here, we expand the theme linking tgase2 to kinase function in a disease context.</p><p>The regulation of tgase2 activity is not fully understood and a recent paper described disturbed tgase2 in CF <xref rid="bib6" ref-type="bibr">[6]</xref>, finding that tgase2 is both over-expressed and over-active in CF cells. Our laboratory has been investigating the membrane-localised activity of nucleoside diphosphate kinase (nm23, NDPK-H1/H2 isoforms; &#x0223c;17&#x000a0;kDa) <xref rid="bib7 bib8 bib9 bib10 bib11 bib12" ref-type="bibr">[7&#x02013;12]</xref>, a multifunctional, hexameric enzyme that not only regulates the balance of cellular nucleotides such as ATP/ADP and GTP/GDP but also controls multiple cellular processes <xref rid="bib13" ref-type="bibr">[13]</xref>. Unexpectedly, during the course of related studies using epithelial membranes derived from sheep tracheal epithelium, we repeatedly observed SDS- and mercaptoethanol-resistant, high molecular weight, NDPK-positive (HMW; &#x0223c;51&#x000a0;kDa) bands in membrane samples. These were not always present, suggestive of regulation and given that others had also reported unexpected ladders of high molecular weight NDPK species <xref rid="bib14" ref-type="bibr">[14]</xref>, we speculated that these HMW, SDS-resistant bands could be cross-linked monomers that would otherwise have dissociated under reducing conditions in sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Our results suggest that tgase2 can regulate NDPK activity.</p></sec><sec sec-type="materials|methods"><label>2</label><title>Materials and methods</title><p>SDS-PAGE, immunoblotting, immunoprecipitations and NDPK phosphorylation assays were carried out as previously described <xref rid="bib8 bib12 bib13" ref-type="bibr">[8,12,13]</xref>. Tgase2 was purchased from Calbiochem. All other reagents were from Sigma, except for radionuclides, obtained from NEN. Quantification of radioactivity was carried out by electronic autoradiography using an InstantImager (Packard). The anti-NDPK antibody used in this work (Santa Cruz) was raised against nm23-H1, but cross-reacts with nm23-H2; we do not distinguish between these two isoforms. Ovine tracheal samples were prepared as previously described <xref rid="bib15" ref-type="bibr">[15]</xref>.</p></sec><sec><label>3</label><title>Results</title><sec><label>3.1</label><title>NDPK forms HMW species in ovine epithelial membranes</title><p>Immunoblots of cytosolic and membrane protein from ovine airway epithelium probed for NDPK show that there is a HMW form (<xref rid="fig1" ref-type="fig">Fig. 1</xref>, lanes 1&#x02212;3) that is only detected in the membrane compartment (<xref rid="fig1" ref-type="fig">Fig. 1</xref>, lanes 4+5: equal protein loading from cytosol and membrane, respectively). These unexpected bands corresponded to trimers of the 17&#x000a0;kDa NDPK monomer (<xref rid="fig1" ref-type="fig">Fig. 1</xref>, lanes 1&#x02013;3). HMW bands were sometimes also observed in membranes from human epithelial cell lines (data not shown) and this led us to investigate the relationship between tgase2 and NDPK in human airway cells.</p></sec><sec><label>3.2</label><title>Tgase2 is elevated in a human CF cell model</title><p>If tgase2 dysfunction is associated with the pathophysiology of CF <xref rid="bib6" ref-type="bibr">[6]</xref>, tgase2 should be present in the affected tissues. Immunoblots show that tgase2 is present but there is nearly twice the level in cell membranes derived from CFBE cells, a human bronchial CF cell line expressing the &#x00394;F508-CFTR when compared to the wild-type (WT) equivalent (HBE) (<xref rid="fig2" ref-type="fig">Fig. 2</xref>, lanes 1+2). Tgase2 activity can be inhibited by monodansylcadaverine (MDC) and cellular levels of tgase2 are strongly induced by retinoic acid (RA); these reagents are commonly used to manipulate tgase2 activity. Surprisingly RA treatment (5&#x000a0;&#x003bc;M, 5&#x000a0;days) reduced tgase2 in CFBE membranes three-fold to below that found in untreated WT HBE membranes (<xref rid="fig2" ref-type="fig">Fig. 2</xref>, compare lanes 4 and 1). The inhibitory effect of RA on HBE cell membrane tgase2 levels was more modest (lanes 3 and 1). By contrast, MDC treatment (50&#x000a0;&#x003bc;M, 5&#x000a0;days) of the cells dramatically reduced membrane-bound tgase2, but maintained the differential between WT and CF such that some residual tgase2 was detectable in CF but not wild-type cell membranes (<xref rid="fig2" ref-type="fig">Fig. 2</xref>, lanes 5+6).</p></sec><sec><label>3.3</label><title>NDPK co-immunoprecipitates with tgase2</title><p>Anti-tgase2 immunoprecipitates from HBE and CFBE membranes were probed for associated NDPK. <xref rid="fig3" ref-type="fig">Fig. 3</xref> demonstrates that NDPK precipitates with tgase2 in both cell types and that the interaction is only abolished by an additional wash in 2&#x000a0;M NaCl suggesting tight association. Control precipitates with no antibody or irrelevant IgG were negative for NDPK.</p></sec><sec><label>3.4</label><title>NDPK activity can be altered by exogenous tgase2, but only if it originates from cytosol</title><p>We incubated membrane and cytosolic fractions from HBE cells with exogenous tgase2, and then tested for NDPK activity. Membrane extracts were unaffected by tgase2, but cytosolic NDPK activity was reduced (<xref rid="fig4" ref-type="fig">Fig. 4</xref>). This is consistent with the idea that membrane-associated NDPK is already cross-linked or in some way resistant to the actions of transglutaminase for example by lying within a multiprotein complex involving the CFTR ion channel and AMP-activated protein kinase <xref rid="bib16 bib17" ref-type="bibr">[16,17]</xref>, so no change is observed.</p></sec><sec><label>3.5</label><title>NDPK activity is affected by tgase2 modulation</title><p>For unknown reasons, NDPK is dysfunctional in CF epithelium <xref rid="bib18" ref-type="bibr">[18]</xref>. We investigated whether the RA &#x02018;normalisation&#x02019; of tgase2 levels would result in restoration of NDPK function in CF cells. We found that both the histidine autophosphorylation <xref rid="bib10" ref-type="bibr">[10]</xref> and the transferase activity of NDPK measured as GTP production <xref rid="bib7 bib8" ref-type="bibr">[7,8]</xref> were restored to WT levels after a five-day treatment of CFBE cells with 5&#x000a0;&#x003bc;M RA (<xref rid="fig5" ref-type="fig">Fig. 5</xref>, bottom panels). MDC treatment also inhibited WT NDPK activity to similar levels to those found in CF (<xref rid="fig5" ref-type="fig">Fig. 5</xref>, top panels).</p></sec></sec><sec><label>4</label><title>Discussion</title><p>Thus, we have shown that NDPK can exist as a multimeric, SDS-resistant complex and that manipulation of tgase2 alters NDPK function. The difference in NDPK activity between CF membranes and wild-type membranes can be normalised. Our data also demonstrate that a fraction of cellular tgase2 co-immunoprecipitates with NDPK, suggesting that they are associated proteins.</p><p>Tgase2 is identical to the G-protein G&#x003b1;<sub>h</sub><xref rid="bib19" ref-type="bibr">[19]</xref>, implicating [GTP] in its regulation. One of the key roles of NDPK is maintenance of GTP levels local to G-proteins at the membrane <xref rid="bib20" ref-type="bibr">[20]</xref>. Ca<sup>2+</sup> and GTP are antagonistic in their regulation of tgase2 activity; Ca<sup>2+</sup> is stimulatory, GTP inhibitory. Its transglutaminase or GTPase activities are reported to predominate, depending on its subcellular localisation to cytosol or membrane, respectively <xref rid="bib21" ref-type="bibr">[21]</xref>. A disturbed tgase2-NDPK axis could have major implications, e.g. in the regulatory connection between tgase2 and the ras oncogene <xref rid="bib22" ref-type="bibr">[22]</xref>, which affects NDPK activity <xref rid="bib23" ref-type="bibr">[23]</xref>. CFTR itself is regulated by unidentified G-proteins <xref rid="bib24 bib25" ref-type="bibr">[24,25]</xref> and is also reported to be regulated by calcium <italic>via</italic> unknown pathways <xref rid="bib26" ref-type="bibr">[26]</xref>. Tgase2 has been reported to directly regulate adenylyl cyclase and, therefore, <xref rid="bib27 bib28" ref-type="bibr">[27,28]</xref> is known to be both activated and induced by cyclic adenosine monophosphate (cAMP) <xref rid="bib29" ref-type="bibr">[29]</xref>, the major activator of CFTR. We note that NDPK is also regulated by cAMP <xref rid="bib30" ref-type="bibr">[30]</xref>.</p><p>The data in <xref rid="fig4" ref-type="fig">Fig. 4</xref> suggest that the activity of NDPK is specifically held in check in the membrane by drugs known to regulate tgase2. Interestingly, suitable Q/K residues for cross-linking exist in close proximity at interfaces between NDPK monomers <xref rid="bib31" ref-type="bibr">[31]</xref> and K31 and Q111 are conserved in the ubiquitous NDPK-H1 and H2 isoforms. There is only one report linking tgase2 activity with CF. Maiuri et al<italic>.</italic><xref rid="bib6" ref-type="bibr">[6]</xref> showed recently that tgase2 activity is elevated in CF tissues and that PPAR&#x003b3; is a substrate for this activity. Here we suggest that NDPK is a further probable substrate for this excess cross-linking activity, which might explain our earlier observation of NDPK dysfunction in CF membranes <xref rid="bib18" ref-type="bibr">[18]</xref>.</p><p>We have recently reported a complex relationship between membrane-local NDPK, its co-precipitating partner AMP-activated kinase, GTP and the differential phosphorylation of NDPK itself on histidine and serine residues. The latter was promoted by the presence of GTP <xref rid="bib13" ref-type="bibr">[13]</xref>. Since the GTP produced by NDPK could also regulate tgase2 activity, this relationship could form a tight feedback loop that could control the membrane-localised metabolic environment. In this context, it may be pertinent that membrane-bound, epithelial NDPK can interact with the metabolic sensor AMP-activated protein kinase (AMPK) <xref rid="bib13" ref-type="bibr">[13]</xref>, which in turn is known to bind CFTR. Our observations on RA are unexpected in that they normalise NDPK function in CF whilst reducing tgase2 in the membrane. Others, whilst looking for ubiquitinated NDPK, observed curious ladders of NDPK high molecular weight species when they were expecting the usual smear of NDPK suggestive of poly-ubiquitination <xref rid="bib14" ref-type="bibr">[14]</xref>. Whatever the mechanism, our observed normalisation of tgase2 levels with RA treatment, coupled with the elevation of NDPK activity, indicates that RA (or tgase2 inhibitors) could be promising therapies for CF. Inhalation of aerosolised RA has already been tested as a therapy for lung cancer <xref rid="bib32" ref-type="bibr">[32]</xref> and as an alternative means of administering supplemental vitamin A <xref rid="bib33" ref-type="bibr">[33]</xref> making this route a viable approach to treat the CF lung. Thus two independent studies concur that tgase2 is overexpressed and is likely to be over-active in CF cells. Further investigation of tgase2 regulation is warranted in CF because fibrotic lung destruction is a major cause of CF morbidity.</p></sec></body><back><ack><title>Acknowledgements</title><p>This work was funded by the Wellcome Trust grant numbers 079965/Z/06/Z, 069150/Z/02/Z and 061003/Z/00/Z.</p></ack><ref-list><title>References</title><ref id="bib1"><label>[1]</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Serban</surname><given-names>D.E.</given-names></name><name><surname>Florescu</surname><given-names>P.</given-names></name><name><surname>Miu</surname><given-names>N.</given-names></name></person-group><article-title>Fibrosing colonopathy revealing cystic fibrosis in a neonate before any pancreatic enzyme supplementation</article-title><source>J Pediatr. Gastroenterol. Nutr.</source><year>2002</year><volume>35</volume><fpage>356</fpage><lpage>359</lpage><pub-id pub-id-type="pmid">12352527</pub-id></citation></ref><ref id="bib2"><label>[2]</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lewindon</surname><given-names>P.J.</given-names></name><name><surname>Pereira</surname><given-names>T.N.</given-names></name><name><surname>Hoskins</surname><given-names>A.C.</given-names></name><name><surname>Bridle</surname><given-names>K.R.</given-names></name><name><surname>Williamson</surname><given-names>R.M.</given-names></name><name><surname>Shepherd</surname><given-names>R.W.</given-names></name><name><surname>Ramm</surname><given-names>G.A.</given-names></name></person-group><article-title>The role of hepatic stellate cells and transforming growth factor-&#x003b2;1 in cystic fibrosis liver disease</article-title><source>Am. J. Pathol.</source><year>2002</year><volume>160</volume><fpage>1705</fpage><lpage>1715</lpage><pub-id pub-id-type="pmid">12000722</pub-id></citation></ref><ref id="bib3"><label>[3]</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Griffin</surname><given-names>M.</given-names></name><name><surname>Casadio</surname><given-names>R.</given-names></name><name><surname>Bergamini</surname><given-names>C.M.</given-names></name></person-group><article-title>Transglutaminases: nature&#x02019;s biological glues</article-title><source>Biochem. J.</source><year>2002</year><volume>368</volume><fpage>377</fpage><lpage>396</lpage><pub-id pub-id-type="pmid">12366374</pub-id></citation></ref><ref id="bib4"><label>[4]</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname><given-names>K.C.</given-names></name><name><surname>Gray</surname><given-names>C.D.</given-names></name><name><surname>Sivasubramanian</surname><given-names>N.</given-names></name><name><surname>Im</surname><given-names>M.J.</given-names></name></person-group><article-title>Interaction site of GTP binding Gh (transglutaminase II) with phospholipase C</article-title><source>J. Biol. Chem.</source><year>1995</year><volume>270</volume><fpage>27058</fpage><lpage>27062</lpage><pub-id pub-id-type="pmid">7592956</pub-id></citation></ref><ref id="bib5"><label>[5]</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hebert</surname><given-names>S.S.</given-names></name><name><surname>Daviau</surname><given-names>A.</given-names></name><name><surname>Grondin</surname><given-names>G.</given-names></name><name><surname>Latreille</surname><given-names>M.</given-names></name><name><surname>Aubin</surname><given-names>R.A.</given-names></name><name><surname>Blouin</surname><given-names>R.</given-names></name></person-group><article-title>The mixed lineage kinase DLK is oligomerized by tissue transglutaminase during apoptosis</article-title><source>J. Biol. Chem.</source><year>2000</year><volume>275</volume><fpage>32482</fpage><lpage>32490</lpage><pub-id pub-id-type="pmid">10922377</pub-id></citation></ref><ref id="bib6"><label>[6]</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maiuri</surname><given-names>L.</given-names></name></person-group><article-title>Tissue transglutaminase activation modulates inflammation in cystic fibrosis via PPARg down-regulation</article-title><source>J. Immunol.</source><year>2008</year><volume>180</volume><fpage>7697</fpage><lpage>7705</lpage><pub-id pub-id-type="pmid">18490773</pub-id></citation></ref><ref id="bib7"><label>[7]</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marshall</surname><given-names>L.J.</given-names></name><name><surname>Muimo</surname><given-names>R.</given-names></name><name><surname>Riemen</surname><given-names>C.E.</given-names></name><name><surname>Mehta</surname><given-names>A.</given-names></name></person-group><article-title>Na+ and K+ regulate the phosphorylation state of nucleoside diphosphate kinase in human airway epithelium</article-title><source>Am. J. Physiol.</source><year>1999</year><volume>276</volume><fpage>C109</fpage><lpage>C119</lpage><pub-id pub-id-type="pmid">9886926</pub-id></citation></ref><ref id="bib8"><label>[8]</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Muimo</surname><given-names>R.</given-names></name><name><surname>Banner</surname><given-names>S.J.</given-names></name><name><surname>Marshall</surname><given-names>L.J.</given-names></name><name><surname>Mehta</surname><given-names>A.</given-names></name></person-group><article-title>Nucleoside diphosphate kinase and Cl-sensitive protein phosphorylation in apical membranes from ovine airway epithelium</article-title><source>Am. J. Respir. Cell Mol. Biol.</source><year>1998</year><volume>18</volume><fpage>270</fpage><lpage>278</lpage><pub-id pub-id-type="pmid">9476915</pub-id></citation></ref><ref id="bib9"><label>[9]</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Muimo</surname><given-names>R.</given-names></name><name><surname>Crawford</surname><given-names>R.M.</given-names></name><name><surname>Mehta</surname><given-names>A.</given-names></name></person-group><article-title>Nucleoside diphosphate kinase A as a controller of AMP-kinase in airway epithelia</article-title><source>J. Bioenerg. Biomembr.</source><year>2006</year><volume>38</volume><fpage>181</fpage><lpage>187</lpage><pub-id pub-id-type="pmid">17039396</pub-id></citation></ref><ref id="bib10"><label>[10]</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Treharne</surname><given-names>K.J.</given-names></name><name><surname>Riemen</surname><given-names>C.E.</given-names></name><name><surname>Marshall</surname><given-names>L.J.</given-names></name><name><surname>Muimo</surname><given-names>R.</given-names></name><name><surname>Mehta</surname><given-names>A.</given-names></name></person-group><article-title>Nucleoside diphosphate kinase &#x02013; a component of the [Na+]- and [Cl&#x02212;]-sensitive phosphorylation cascade in human and murine airway epithelium</article-title><source>Pflugers. Arch.</source><year>2001</year><volume>443</volume><issue>Suppl. 1</issue><fpage>S97</fpage><lpage>102</lpage><pub-id pub-id-type="pmid">11845312</pub-id></citation></ref><ref id="bib11"><label>[11]</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Treharne</surname><given-names>K.J.</given-names></name><name><surname>Crawford</surname><given-names>R.M.</given-names></name><name><surname>Mehta</surname><given-names>A.</given-names></name></person-group><article-title>CFTR, chloride concentration and cell volume: could mammalian protein histidine phosphorylation play a latent role?</article-title><source>Exp. Physiol.</source><year>2006</year><volume>91</volume><fpage>131</fpage><lpage>139</lpage><pub-id pub-id-type="pmid">16219660</pub-id></citation></ref><ref id="bib12"><label>[12]</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Treharne</surname><given-names>K.J.</given-names></name><name><surname>Marshall</surname><given-names>L.J.</given-names></name><name><surname>Mehta</surname><given-names>A.</given-names></name></person-group><article-title>A novel chloride-dependent GTP-utilizing protein kinase in plasma membranes from human respiratory epithelium</article-title><source>Am. J. Physiol.</source><year>1994</year><volume>267</volume><fpage>L592</fpage><lpage>L601</lpage><pub-id pub-id-type="pmid">7977769</pub-id></citation></ref><ref id="bib13"><label>[13]</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Treharne</surname><given-names>K.J.</given-names></name><name><surname>Best</surname><given-names>O.G.</given-names></name><name><surname>Mehta</surname><given-names>A.</given-names></name></person-group><article-title>The phosphorylation status of membrane-bound nucleoside diphosphate kinase in epithelia and the role of AMP</article-title><source>Mol. Cell. Biochem.</source><year>2009</year><comment>epub</comment></citation></ref><ref id="bib14"><label>[14]</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hochrainer</surname><given-names>K.</given-names></name><name><surname>Kroismayr</surname><given-names>R.</given-names></name><name><surname>Baranyi</surname><given-names>U.</given-names></name><name><surname>Binder</surname><given-names>B.R.</given-names></name><name><surname>Lipp</surname><given-names>J.</given-names></name></person-group><article-title>Highly homologous HERC proteins localize to endosomes and exhibit specific interactions with hPLIC and Nm23B</article-title><source>Cell Mol. Life Sci.</source><year>2008</year><volume>65</volume><fpage>2105</fpage><lpage>2117</lpage><pub-id pub-id-type="pmid">18535780</pub-id></citation></ref><ref id="bib15"><label>[15]</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Muimo</surname><given-names>R.</given-names></name><name><surname>Hornickova</surname><given-names>Z.</given-names></name><name><surname>Riemen</surname><given-names>C.E.</given-names></name><name><surname>Gerke</surname><given-names>V.</given-names></name><name><surname>Matthews</surname><given-names>H.</given-names></name><name><surname>Mehta</surname><given-names>A.</given-names></name></person-group><article-title>Histidine phosphorylation of annexin I in airway epithelia</article-title><source>J. Biol. Chem.</source><year>2000</year><volume>275</volume><fpage>36632</fpage><lpage>36636</lpage><pub-id pub-id-type="pmid">10956639</pub-id></citation></ref><ref id="bib16"><label>[16]</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kongsuphol</surname><given-names>P.</given-names></name><name><surname>Cassidy</surname><given-names>D.</given-names></name><name><surname>Hieke</surname><given-names>B.</given-names></name><name><surname>Treharne</surname><given-names>K.J.</given-names></name><name><surname>Schreiber</surname><given-names>R.</given-names></name><name><surname>Mehta</surname><given-names>A.</given-names></name><name><surname>Kunzelmann</surname><given-names>K.</given-names></name></person-group><article-title>Mechanistic insight into control of CFTR by AMPK</article-title><source>J. Biol. Chem.</source><year>2008</year><volume>284</volume><fpage>5645</fpage><lpage>5653</lpage><pub-id pub-id-type="pmid">19095655</pub-id></citation></ref><ref id="bib17"><label>[17]</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>King</surname><given-names>J.D.</given-names></name><name><surname>Fitch</surname><given-names>A.C.</given-names></name><name><surname>Lee</surname><given-names>J.K.</given-names></name><name><surname>McCane</surname><given-names>J.E.</given-names></name><name><surname>Mak</surname><given-names>D.O.</given-names></name><name><surname>Foskett</surname><given-names>J.K.</given-names></name><name><surname>Hallows</surname><given-names>K.R.</given-names></name></person-group><article-title>AMP-activated protein kinase phosphorylation of the R domain inhibits PKA stimulation of CFTR</article-title><source>Am. J. Physiol. Cell Physiol.</source><year>2009</year><volume>297</volume><fpage>C94</fpage><lpage>C101</lpage><pub-id pub-id-type="pmid">19419994</pub-id></citation></ref><ref id="bib18"><label>[18]</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Treharne</surname><given-names>K.J.</given-names></name><name><surname>Mehta</surname><given-names>A.</given-names></name><name><surname>Muimo</surname><given-names>R.</given-names></name></person-group><article-title>NDPK, a protein kinase defective in CF, binds to and is regulated by AMPK, a CFTR-associated protein</article-title><source>Pediatric Pulmonol.</source><year>2001</year><volume>S22</volume><fpage>240</fpage></citation></ref><ref id="bib19"><label>[19]</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakaoka</surname><given-names>H.</given-names></name><name><surname>Perez</surname><given-names>D.M.</given-names></name><name><surname>Baek</surname><given-names>K.J.</given-names></name><name><surname>Das</surname><given-names>T.</given-names></name><name><surname>Husain</surname><given-names>A.</given-names></name><name><surname>Misono</surname><given-names>K.</given-names></name><name><surname>Im</surname><given-names>M.J.</given-names></name><name><surname>Graham</surname><given-names>R.M.</given-names></name></person-group><article-title>Gh: a GTP-binding protein with transglutaminase activity and receptor signaling function</article-title><source>Science</source><year>1994</year><volume>264</volume><fpage>1593</fpage><lpage>1596</lpage><pub-id pub-id-type="pmid">7911253</pub-id></citation></ref><ref id="bib20"><label>[20]</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hippe</surname><given-names>H.J.</given-names></name><name><surname>Lutz</surname><given-names>S.</given-names></name><name><surname>Cuello</surname><given-names>F.</given-names></name><name><surname>Knorr</surname><given-names>K.</given-names></name><name><surname>Vogt</surname><given-names>A.</given-names></name><name><surname>Jakobs</surname><given-names>K.H.</given-names></name><name><surname>Wieland</surname><given-names>T.</given-names></name><name><surname>Niroomand</surname><given-names>F.</given-names></name></person-group><article-title>Activation of heterotrimeric G proteins by a high energy phosphate transfer via nucleoside diphosphate kinase (NDPK) B and G&#x003b2; subunits. Specific activation of Gs by an NDPK B.G&#x003b2;&#x003b3; complex in H10 cells</article-title><source>J. Biol. Chem.</source><year>2003</year><volume>278</volume><fpage>7227</fpage><lpage>7233</lpage><pub-id pub-id-type="pmid">12486122</pub-id></citation></ref><ref id="bib21"><label>[21]</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>H.</given-names></name><name><surname>Park</surname><given-names>E.S.</given-names></name><name><surname>Lee</surname><given-names>H.S.</given-names></name><name><surname>Yun</surname><given-names>H.Y.</given-names></name><name><surname>Kwon</surname><given-names>N.S.</given-names></name><name><surname>Baek</surname><given-names>K.J.</given-names></name></person-group><article-title>Distinct characteristic of Gh (transglutaminase II) by compartment: GTPase and transglutaminase activities</article-title><source>Biochem. Biophys. Res. Commun.</source><year>2001</year><volume>284</volume><fpage>496</fpage><lpage>500</lpage><pub-id pub-id-type="pmid">11394908</pub-id></citation></ref><ref id="bib22"><label>[22]</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kosa</surname><given-names>K.</given-names></name><name><surname>Meyers</surname><given-names>K.</given-names></name><name><surname>De Luca</surname><given-names>L.M.</given-names></name></person-group><article-title>Transformation of NIH3T3 cells with ras oncogenes abrogates the retinoic acid induction of tissue transglutaminase</article-title><source>Biochem. Biophys. Res. Commun.</source><year>1993</year><volume>196</volume><fpage>1025</fpage><lpage>1033</lpage><pub-id pub-id-type="pmid">7504461</pub-id></citation></ref><ref id="bib23"><label>[23]</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>J.</given-names></name><name><surname>Tseng</surname><given-names>Y.H.</given-names></name><name><surname>Kantor</surname><given-names>J.D.</given-names></name><name><surname>Rhodes</surname><given-names>C.J.</given-names></name><name><surname>Zetter</surname><given-names>B.R.</given-names></name><name><surname>Moyers</surname><given-names>J.S.</given-names></name><name><surname>Kahn</surname><given-names>C.R.</given-names></name></person-group><article-title>Interaction of the Ras-related protein associated with diabetes rad and the putative tumor metastasis suppressor nm23 provides a novel mechanism of GTPase regulation</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1999</year><volume>96</volume><fpage>14911</fpage><lpage>14918</lpage><pub-id pub-id-type="pmid">10611312</pub-id></citation></ref><ref id="bib24"><label>[24]</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reddy</surname><given-names>M.M.</given-names></name><name><surname>Quinton</surname><given-names>P.M.</given-names></name></person-group><article-title>CAMP-independent phosphorylation activation of CFTR by G proteins in native human sweat duct</article-title><source>Am. J. Physiol. Cell Physiol.</source><year>2001</year><volume>280</volume><fpage>C604</fpage><lpage>C613</lpage><pub-id pub-id-type="pmid">11171580</pub-id></citation></ref><ref id="bib25"><label>[25]</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reddy</surname><given-names>M.M.</given-names></name><name><surname>Sun</surname><given-names>D.</given-names></name><name><surname>Quinton</surname><given-names>P.M.</given-names></name></person-group><article-title>Apical heterotrimeric g-proteins activate CFTR in the native sweat duct</article-title><source>J. Membr. Biol.</source><year>2001</year><volume>179</volume><fpage>51</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">11155209</pub-id></citation></ref><ref id="bib26"><label>[26]</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Namkung</surname><given-names>W.</given-names></name><name><surname>Lee</surname><given-names>J.A.</given-names></name><name><surname>Ahn</surname><given-names>W.</given-names></name><name><surname>Han</surname><given-names>W.</given-names></name><name><surname>Kwon</surname><given-names>S.W.</given-names></name><name><surname>Ahn</surname><given-names>D.S.</given-names></name><name><surname>Kim</surname><given-names>K.H.</given-names></name><name><surname>Lee</surname><given-names>M.G.</given-names></name></person-group><article-title>Ca2+ activates cystic fibrosis transmembrane conductance regulator- and Cl-dependent HCO3 transport in pancreatic duct cells</article-title><source>J. Biol. Chem.</source><year>2003</year><volume>278</volume><fpage>200</fpage><lpage>207</lpage><pub-id pub-id-type="pmid">12409301</pub-id></citation></ref><ref id="bib27"><label>[27]</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Milne</surname><given-names>D.M.</given-names></name><name><surname>Campbell</surname><given-names>L.E.</given-names></name><name><surname>Campbell</surname><given-names>D.G.</given-names></name><name><surname>Meek</surname><given-names>D.W.</given-names></name></person-group><article-title>P53 is phosphorylated in vitro and in vivo by an ultraviolet radiation-induced protein kinase characteristic of the c-Jun kinase, JNK1</article-title><source>J. Biol. Chem.</source><year>1995</year><volume>270</volume><fpage>5511</fpage><lpage>5518</lpage><pub-id pub-id-type="pmid">7890669</pub-id></citation></ref><ref id="bib28"><label>[28]</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tucholski</surname><given-names>J.</given-names></name><name><surname>Johnson</surname><given-names>G.V.</given-names></name></person-group><article-title>Tissue transglutaminase directly regulates adenylyl cyclase resulting in enhanced cAMP-response element-binding protein (CREB) activation</article-title><source>J. Biol. Chem.</source><year>2003</year><volume>278</volume><fpage>26838</fpage><lpage>26843</lpage><pub-id pub-id-type="pmid">12743114</pub-id></citation></ref><ref id="bib29"><label>[29]</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maddox</surname><given-names>A.M.</given-names></name><name><surname>Haddox</surname><given-names>M.K.</given-names></name></person-group><article-title>Characteristics of cyclic AMP enhancement of retinoic acid induction of increased transglutaminase activity in HL60 cells</article-title><source>Exp. Cell Biol.</source><year>1988</year><volume>56</volume><fpage>49</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">2903078</pub-id></citation></ref><ref id="bib30"><label>[30]</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Anciaux</surname><given-names>K.</given-names></name><name><surname>Van Dommelen</surname><given-names>K.</given-names></name><name><surname>Willems</surname><given-names>R.</given-names></name><name><surname>Roymans</surname><given-names>D.</given-names></name><name><surname>Slegers</surname><given-names>H.</given-names></name></person-group><article-title>Inhibition of nucleoside diphosphate kinase (NDPK/nm23) by cAMP analogues</article-title><source>FEBS Lett.</source><year>1997</year><volume>400</volume><fpage>75</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">9000516</pub-id></citation></ref><ref id="bib31"><label>[31]</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Min</surname><given-names>K.</given-names></name></person-group><article-title>Crystallization and preliminary X-ray crystallographic analysis of human nucleoside diphosphate kinase A</article-title><source>Acta Crystallogr. D Biol. Crystallogr.</source><year>2000</year><volume>56</volume><fpage>503</fpage><lpage>504</lpage><pub-id pub-id-type="pmid">10739934</pub-id></citation></ref><ref id="bib32"><label>[32]</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kohlhaufl</surname><given-names>M.</given-names></name></person-group><article-title>Inhalation of aerosolized vitamin A: reversibility of metaplasia and dysplasia of human respiratory epithelia &#x02013; a prospective pilot study</article-title><source>Eur. J. Med. Res.</source><year>2002</year><volume>7</volume><fpage>72</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">11891147</pub-id></citation></ref><ref id="bib33"><label>[33]</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Biesalski</surname><given-names>H.</given-names></name><name><surname>Reifen</surname><given-names>R.</given-names></name><name><surname>Furst</surname><given-names>P.</given-names></name><name><surname>Edris</surname><given-names>M.</given-names></name></person-group><article-title>Retinyl palmitate supplementation by inhalation of an aerosol improves vitamin A status of preschool children in Gondar (Ethiopia)</article-title><source>Br. J. Nutr.</source><year>1999</year><volume>82</volume><fpage>179</fpage><lpage>182</lpage><pub-id pub-id-type="pmid">10655964</pub-id></citation></ref></ref-list></back><floats-wrap><fig id="fig1"><label>Fig. 1</label><caption><p>NDPK immunoblots of ovine airway epithelial membrane protein separated on SDS-PAGE, showing consistent appearance of 51&#x000a0;kDa HMW bands in three independent preparations (lanes 1&#x02013;3). Equivalent loadings of cytosolic (lane 4) and membrane (lane 5) protein showed that the HMW species is absent from the cytosolic fraction. The antibody used and the membrane preparation protocol are described in the methods for this and subsequent figures.</p></caption><graphic xlink:href="gr1"/></fig><fig id="fig2"><label>Fig. 2</label><caption><p>Immunoblot and densitometric quantification of tgase2 (mouse monoclonal antibody cocktail, Neomarkers MS-300-p, 1:1000) in HBE and CFBE membranes isolated from cells pretreated with retinoic acid (RA, 5&#x000a0;&#x003bc;M, 5&#x000a0;days) and monodansylcadaverine (MDC, 50&#x000a0;&#x003bc;M, 5&#x000a0;days). Identical membrane protein loading (20&#x000a0;&#x003bc;g) was present in each lane.</p></caption><graphic xlink:href="gr2"/></fig><fig id="fig3"><label>Fig. 3</label><caption><p>Immunoprecipitation from HBE and CFBE membranes using a specific anti-tgase2 antibody followed by immunoblotting for NDPK. The &#x02018;IP&#x02019; sample in each case has been washed several times and represents NDPK bound to tgase. Control lanes show no antibody and irrelevant IgG samples. See Refs. <xref rid="bib7 bib8 bib9 bib10 bib11 bib12" ref-type="bibr">[7&#x02013;12]</xref> for methods.</p></caption><graphic xlink:href="gr3"/></fig><fig id="fig4"><label>Fig. 4</label><caption><p>16HBE14o cytosolic or membrane extracts were incubated with exogenous tgase2 (1&#x000a0;&#x003bc;g, 4&#x000a0;h) and NDPK activity measured by its phosphorylation (for methods, see Ref. <xref rid="bib13" ref-type="bibr">[13]</xref>). Filled columns show data from samples without tgase2, white columns with tgase2. <italic>n</italic>&#x000a0;=&#x000a0;3&#x000a0;&#x000b1;&#x000a0;S.E.M.</p></caption><graphic xlink:href="gr4"/></fig><fig id="fig5"><label>Fig. 5</label><caption><p>Data showing NDPK phosphorylation (left) and phosphotransferase activity (right) in HBE and CFBE cell lines and the effect of treatment with RA (bottom) and MDC (top). For methods, see Ref. <xref rid="bib13" ref-type="bibr">[13]</xref>. <italic>n</italic>&#x000a0;=&#x000a0;3&#x000a0;&#x000b1;&#x000a0;S.E.M.</p></caption><graphic xlink:href="gr5"/></fig></floats-wrap></article> 